Modalities
2-week audits, design sprints, and fractional product-risk support.
Work
I help teams make safer roadmap decisions without slowing down delivery.
Share your context and I’ll reply within 48 hours with a recommended next step.
Modalities
2-week audits, design sprints, and fractional product-risk support.
Markets
Healthcare, fintech, and enterprise teams under regulatory pressure.
Outcomes
Clearer ownership, better escalation, and faster recovery.
Swipe for more highlights →
Practice model
A simple model: define ownership, align constraints, ship the next safe step.
Operational governance
Set simple decision rights and escalation paths your team can use under pressure.
Product + compliance alignment
Translate constraints into clear roadmap choices and defensible customer messaging.
Who this is for
Who this is for
Ship products teams can sell and operate with confidence—especially when the cost of a wrong decision is measured in incidents, audits, and patient or customer harm.
Best fit
Teams under real operating, trust, or compliance pressure.
Evidence I can help
This work is grounded in shipped systems, not workshop theater.
Not a fit
Outcomes
What you get
Most teams hire me to turn a fuzzy product-risk problem into a clear decision, documented owners, and a next move the team can execute without extra drift.
Outcome 1
Improved telehealth reachability with verified caller ID and trust signals.
Expect a concrete decision artifact, named ownership, and a next-step plan you can act on quickly.
Outcome 2
Reduced avoidable escalations after unifying records and redefining success.
Expect a concrete decision artifact, named ownership, and a next-step plan you can act on quickly.
Outcome 3
Faster high-risk review cycles with clearer ownership and auditability.
Expect a concrete decision artifact, named ownership, and a next-step plan you can act on quickly.
Case studies
Proof
Each case study shows the problem, the constraints, what changed, and the visible outcome before you open anything deeper.
How I protect your team: I don’t name sensitive internal politics, and I never publish identifying details without consent. Metrics stay rounded and de-identified, artifacts are redacted, and access is limited to the stakeholders you choose. Quantified deltas are shared in redacted form when available.
Built trusted caller identity and guardrails so clinicians could reach patients without exposing private numbers.
Evidence
Outcome
Reframed success metrics around completed care plans to reduce rework and clinician load.
Evidence
Outcome
Balanced automated guidance with human oversight so recommendations stayed compliant and trusted.
Evidence
Outcome
Engagements
Engagement options
Every option is scoped to produce a decision, written recap, and visible ownership—not an open-ended advisory fog.
Option 1
Fast decision support when you need clear ownership, risk tradeoffs, and next actions.
Best when
What happens first
What success looks like
Option 2
Focused engagement to map failure modes, who decides what, and escalation behavior before risk compounds.
Best when
What happens first
What success looks like
Option 3
Senior product-risk judgment and operating cadence without a full-time executive hire.
Best when
What happens first
What success looks like
Start a conversation
Ready to start
Send a short brief. I’ll reply with the smallest engagement that gets your team to a better decision.
Step 1
Share your context, the decision that feels blocked, and any timing pressure. I’ll respond within 48 hours with a recommended path.
Available now for new client projects
Booking discovery calls this month.
Best fit for healthcare and other trust-critical product teams.
Share your context and goals to get a recommended next step.
Step 2
Share the brief
Use the intake below to draft the email in one pass. It is the same path the TOC, sticky CTA, and endcap point to.
Prefer direct contact?
If email or LinkedIn is easier, use those channels and send the same short brief.
No parallel funnels here—every path leads to the same scoped recommendation.